Hydreight Technologies Statistics

Total Valuation

TSXV:NURS has a market cap or net worth of CAD 77.86 million. The enterprise value is 72.63 million.

Market Cap	77.86M
Enterprise Value	72.63M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:NURS has 45.00 million shares outstanding. The number of shares has increased by 4.79% in one year.

Current Share Class	45.00M
Shares Outstanding	45.00M
Shares Change (YoY)	+4.79%
Shares Change (QoQ)	+4.23%
Owned by Insiders (%)	3.58%
Owned by Institutions (%)	n/a
Float	18.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.52
PB Ratio	24.72
P/TBV Ratio	57.79
P/FCF Ratio	56.79
P/OCF Ratio	56.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-961.37
EV / Sales	4.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	52.97

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.26.

Current Ratio	1.50
Quick Ratio	1.40
Debt / Equity	0.26
Debt / EBITDA	21.51
Debt / FCF	0.59
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -12.98% and return on invested capital (ROIC) is -8.87%.

Return on Equity (ROE)	-12.98%
Return on Assets (ROA)	-2.33%
Return on Invested Capital (ROIC)	-8.87%
Return on Capital Employed (ROCE)	-4.99%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	3.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +486.44% in the last 52 weeks. The beta is 0.40, so TSXV:NURS's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+486.44%
50-Day Moving Average	1.74
200-Day Moving Average	1.27
Relative Strength Index (RSI)	46.37
Average Volume (20 Days)	139,797

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:NURS had revenue of CAD 17.21 million and -75,545 in losses. Loss per share was -0.00.

Revenue	17.21M
Gross Profit	5.97M
Operating Income	-197,807
Pretax Income	-75,545
Net Income	-75,545
EBITDA	37,780
EBIT	-197,807
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 6.04 million in cash and 812,493 in debt, giving a net cash position of 5.23 million or 0.12 per share.

Cash & Cash Equivalents	6.04M
Total Debt	812,493
Net Cash	5.23M
Net Cash Per Share	0.12
Equity (Book Value)	3.15M
Book Value Per Share	0.07
Working Capital	2.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.37 million and capital expenditures -1,221, giving a free cash flow of 1.37 million.

Operating Cash Flow	1.37M
Capital Expenditures	-1,221
Free Cash Flow	1.37M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 34.69%, with operating and profit margins of -1.15% and -0.44%.

Gross Margin	34.69%
Operating Margin	-1.15%
Pretax Margin	-0.44%
Profit Margin	-0.44%
EBITDA Margin	0.22%
EBIT Margin	-1.15%
FCF Margin	7.97%

Dividends & Yields

TSXV:NURS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.79%
Shareholder Yield	n/a
Earnings Yield	-0.10%
FCF Yield	1.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.

Last Split Date	Nov 25, 2022
Split Type	Reverse
Split Ratio	0.1546061

Scores

TSXV:NURS has an Altman Z-Score of 4.37 and a Piotroski F-Score of 3.

Altman Z-Score	4.37
Piotroski F-Score	3